Development of hyperkalemia following treatment with dapagliflozin (DAPA) in a patient with type 2 diabetes after bilateral adrenalectomy
Crossref DOI link: https://doi.org/10.1007/s13730-017-0286-x
Published Online: 2017-11-13
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyaoka, Daichi
Tsuda, Akihiro
Hayashi, Noriyuki
Toi, Norikazu
Yamasaki, Akiyo
Nagata, Yuki
Nakatani, Shinya
Kurajoh, Masafumi
Yamada, Shinsuke
Morioka, Tomoaki
Imanishi, Yasuo
Emoto, Masanori
Inaba, Masaaki
License valid from 2017-11-13